A Day Up For SAB Biotherapeutics Inc.
Thu, Apr 13, 2023 at 07:12 PM
SAB Biotherapeutics Inc. (SABS:NASDAQ) shot up at $0.76, representing a gain of 97.6%. On Thu, Apr 13, 2023, SABS:NASDAQ hit a New 2-Week High of $0.76. The stock got featured on our News Catalysts scanner on Thu, Apr 13, 2023 at 09:10 AM in the 'BIOTECH' category. From Thu, Mar 30, 2023, the stock recorded 44.44% Up Days and 30.00% Green Days
About SAB Biotherapeutics Inc. (SABS:NASDAQ)
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company advancing a class of immunotherapies based on its human polyclonal antibodies.
Top 10 Gainers:
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 345.63%
- Inpixon (INPX:NASDAQ), 128.43%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 97.58%
- Marpai Inc. (MRAI:NASDAQ), 90.29%
- Predictive Oncology Inc. (POAI:NASDAQ), 77.86%
- Auddia Inc. (AUUD:NASDAQ), 67.93%
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 49.89%
- Pulse Biosciences, Inc. (PLSE:NASDAQ), 40.12%
- Consolidated Communications Holdings, Inc. (CNSL:NASDAQ), 38.77%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 36.97%